Financhill
Buy
57

ISRG Quote, Financials, Valuation and Earnings

Last price:
$488.78
Seasonality move :
13.4%
Day range:
$476.57 - $492.28
52-week range:
$364.17 - $616.00
Dividend yield:
0%
P/E ratio:
75.58x
P/S ratio:
21.00x
P/B ratio:
10.51x
Volume:
4.2M
Avg. volume:
2M
1-year change:
26.05%
Market cap:
$172.8B
Revenue:
$8.4B
EPS (TTM):
$6.41

Price Performance History

Performance vs. Valuation Benchmarks

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Competitors

Company Revenue Forecast Earnings Forecast Revenue Growth Forecast Earnings Growth Forecast Analyst Price Target Median
ISRG
Intuitive Surgical
$2.2B $1.79 15.66% 15.62% $632.53
ABT
Abbott Laboratories
$11B $1.34 4.19% 52.11% $136.26
BSX
Boston Scientific
$4.4B $0.66 18.49% 103.33% $115.62
PODD
Insulet
$582M $1.02 23.07% 6.17% $314.06
SYK
Stryker
$6.4B $3.87 8.28% 33.5% $424.43
TFX
Teleflex
$813.2M $3.88 -4.16% 826.82% $168.21
Company Price Analyst Target Market Cap P/E Ratio Dividend per Share Dividend Yield Price / LTM Sales
ISRG
Intuitive Surgical
$484.44 $632.53 $172.8B 75.58x $0.00 0% 21.00x
ABT
Abbott Laboratories
$126.71 $136.26 $219.8B 16.56x $0.59 1.77% 5.28x
BSX
Boston Scientific
$97.16 $115.62 $143.4B 77.73x $0.00 0% 8.62x
PODD
Insulet
$255.44 $314.06 $17.9B 44.12x $0.00 0% 9.11x
SYK
Stryker
$369.53 $424.43 $141B 47.62x $0.84 0.88% 6.31x
TFX
Teleflex
$137.71 $168.21 $6.4B 96.98x $0.34 0.99% 2.13x
Company Total Debt / Total Capital Beta Debt to Equity Quick Ratio
ISRG
Intuitive Surgical
-- 1.599 -- 3.08x
ABT
Abbott Laboratories
22.86% 0.603 7.72% 1.23x
BSX
Boston Scientific
32.79% 0.683 8.05% 0.46x
PODD
Insulet
53.47% 1.510 7.6% 2.50x
SYK
Stryker
39.72% 1.452 10.13% 1.11x
TFX
Teleflex
27.91% 1.867 20.11% 1.15x
Company Gross Profit Operating Income Return on Invested Capital Return on Common Equity EBIT Margin Free Cash Flow
ISRG
Intuitive Surgical
$1.6B $734.9M 15.6% 15.6% 30.45% $510.6M
ABT
Abbott Laboratories
$6B $1.9B 24.06% 32.63% 19.74% $2.1B
BSX
Boston Scientific
$3.1B $790M 5.97% 8.96% 14.58% $1.2B
PODD
Insulet
$430.9M $109.3M 17.64% 43.11% 20.08% $91.7M
SYK
Stryker
$4.2B $1.6B 9.04% 15.22% 24.21% $1.7B
TFX
Teleflex
$439.9M $140.8M 1.13% 1.57% -13.59% $170.4M

Intuitive Surgical vs. Competitors

  • Which has Higher Returns ISRG or ABT?

    Abbott Laboratories has a net margin of 28.41% compared to Intuitive Surgical's net margin of 84.1%. Intuitive Surgical's return on equity of 15.6% beat Abbott Laboratories's return on equity of 32.63%.

    Company Gross Margin Earnings Per Share Invested Capital
    ISRG
    Intuitive Surgical
    68.04% $1.88 $16.5B
    ABT
    Abbott Laboratories
    54.97% $5.27 $62B
  • What do Analysts Say About ISRG or ABT?

    Intuitive Surgical has a consensus price target of $632.53, signalling upside risk potential of 30.57%. On the other hand Abbott Laboratories has an analysts' consensus of $136.26 which suggests that it could grow by 7.54%. Given that Intuitive Surgical has higher upside potential than Abbott Laboratories, analysts believe Intuitive Surgical is more attractive than Abbott Laboratories.

    Company Buy Ratings Hold Ratings Sell Ratings
    ISRG
    Intuitive Surgical
    14 10 0
    ABT
    Abbott Laboratories
    13 6 0
  • Is ISRG or ABT More Risky?

    Intuitive Surgical has a beta of 1.426, which suggesting that the stock is 42.616% more volatile than S&P 500. In comparison Abbott Laboratories has a beta of 0.696, suggesting its less volatile than the S&P 500 by 30.418%.

  • Which is a Better Dividend Stock ISRG or ABT?

    Intuitive Surgical has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Abbott Laboratories offers a yield of 1.77% to investors and pays a quarterly dividend of $0.59 per share. Intuitive Surgical pays -- of its earnings as a dividend. Abbott Laboratories pays out 28.62% of its earnings as a dividend. Abbott Laboratories's payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.

  • Which has Better Financial Ratios ISRG or ABT?

    Intuitive Surgical quarterly revenues are $2.4B, which are smaller than Abbott Laboratories quarterly revenues of $11B. Intuitive Surgical's net income of $685.7M is lower than Abbott Laboratories's net income of $9.2B. Notably, Intuitive Surgical's price-to-earnings ratio is 75.58x while Abbott Laboratories's PE ratio is 16.56x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Intuitive Surgical is 21.00x versus 5.28x for Abbott Laboratories. Usually stocks with elevated PS ratios are considered overvalued.

    Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income
    ISRG
    Intuitive Surgical
    21.00x 75.58x $2.4B $685.7M
    ABT
    Abbott Laboratories
    5.28x 16.56x $11B $9.2B
  • Which has Higher Returns ISRG or BSX?

    Boston Scientific has a net margin of 28.41% compared to Intuitive Surgical's net margin of 12.41%. Intuitive Surgical's return on equity of 15.6% beat Boston Scientific's return on equity of 8.96%.

    Company Gross Margin Earnings Per Share Invested Capital
    ISRG
    Intuitive Surgical
    68.04% $1.88 $16.5B
    BSX
    Boston Scientific
    67.86% $0.38 $32.6B
  • What do Analysts Say About ISRG or BSX?

    Intuitive Surgical has a consensus price target of $632.53, signalling upside risk potential of 30.57%. On the other hand Boston Scientific has an analysts' consensus of $115.62 which suggests that it could grow by 19%. Given that Intuitive Surgical has higher upside potential than Boston Scientific, analysts believe Intuitive Surgical is more attractive than Boston Scientific.

    Company Buy Ratings Hold Ratings Sell Ratings
    ISRG
    Intuitive Surgical
    14 10 0
    BSX
    Boston Scientific
    23 4 0
  • Is ISRG or BSX More Risky?

    Intuitive Surgical has a beta of 1.426, which suggesting that the stock is 42.616% more volatile than S&P 500. In comparison Boston Scientific has a beta of 0.772, suggesting its less volatile than the S&P 500 by 22.845%.

  • Which is a Better Dividend Stock ISRG or BSX?

    Intuitive Surgical has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Boston Scientific offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Intuitive Surgical pays -- of its earnings as a dividend. Boston Scientific pays out -- of its earnings as a dividend.

  • Which has Better Financial Ratios ISRG or BSX?

    Intuitive Surgical quarterly revenues are $2.4B, which are smaller than Boston Scientific quarterly revenues of $4.6B. Intuitive Surgical's net income of $685.7M is higher than Boston Scientific's net income of $566M. Notably, Intuitive Surgical's price-to-earnings ratio is 75.58x while Boston Scientific's PE ratio is 77.73x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Intuitive Surgical is 21.00x versus 8.62x for Boston Scientific. Usually stocks with elevated PS ratios are considered overvalued.

    Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income
    ISRG
    Intuitive Surgical
    21.00x 75.58x $2.4B $685.7M
    BSX
    Boston Scientific
    8.62x 77.73x $4.6B $566M
  • Which has Higher Returns ISRG or PODD?

    Insulet has a net margin of 28.41% compared to Intuitive Surgical's net margin of 16.85%. Intuitive Surgical's return on equity of 15.6% beat Insulet's return on equity of 43.11%.

    Company Gross Margin Earnings Per Share Invested Capital
    ISRG
    Intuitive Surgical
    68.04% $1.88 $16.5B
    PODD
    Insulet
    72.12% $1.39 $2.6B
  • What do Analysts Say About ISRG or PODD?

    Intuitive Surgical has a consensus price target of $632.53, signalling upside risk potential of 30.57%. On the other hand Insulet has an analysts' consensus of $314.06 which suggests that it could grow by 22.95%. Given that Intuitive Surgical has higher upside potential than Insulet, analysts believe Intuitive Surgical is more attractive than Insulet.

    Company Buy Ratings Hold Ratings Sell Ratings
    ISRG
    Intuitive Surgical
    14 10 0
    PODD
    Insulet
    14 4 0
  • Is ISRG or PODD More Risky?

    Intuitive Surgical has a beta of 1.426, which suggesting that the stock is 42.616% more volatile than S&P 500. In comparison Insulet has a beta of 1.285, suggesting its more volatile than the S&P 500 by 28.544%.

  • Which is a Better Dividend Stock ISRG or PODD?

    Intuitive Surgical has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Insulet offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Intuitive Surgical pays -- of its earnings as a dividend. Insulet pays out -- of its earnings as a dividend.

  • Which has Better Financial Ratios ISRG or PODD?

    Intuitive Surgical quarterly revenues are $2.4B, which are larger than Insulet quarterly revenues of $597.5M. Intuitive Surgical's net income of $685.7M is higher than Insulet's net income of $100.7M. Notably, Intuitive Surgical's price-to-earnings ratio is 75.58x while Insulet's PE ratio is 44.12x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Intuitive Surgical is 21.00x versus 9.11x for Insulet. Usually stocks with elevated PS ratios are considered overvalued.

    Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income
    ISRG
    Intuitive Surgical
    21.00x 75.58x $2.4B $685.7M
    PODD
    Insulet
    9.11x 44.12x $597.5M $100.7M
  • Which has Higher Returns ISRG or SYK?

    Stryker has a net margin of 28.41% compared to Intuitive Surgical's net margin of 8.48%. Intuitive Surgical's return on equity of 15.6% beat Stryker's return on equity of 15.22%.

    Company Gross Margin Earnings Per Share Invested Capital
    ISRG
    Intuitive Surgical
    68.04% $1.88 $16.5B
    SYK
    Stryker
    64.85% $1.41 $34.2B
  • What do Analysts Say About ISRG or SYK?

    Intuitive Surgical has a consensus price target of $632.53, signalling upside risk potential of 30.57%. On the other hand Stryker has an analysts' consensus of $424.43 which suggests that it could grow by 14.86%. Given that Intuitive Surgical has higher upside potential than Stryker, analysts believe Intuitive Surgical is more attractive than Stryker.

    Company Buy Ratings Hold Ratings Sell Ratings
    ISRG
    Intuitive Surgical
    14 10 0
    SYK
    Stryker
    13 9 0
  • Is ISRG or SYK More Risky?

    Intuitive Surgical has a beta of 1.426, which suggesting that the stock is 42.616% more volatile than S&P 500. In comparison Stryker has a beta of 0.946, suggesting its less volatile than the S&P 500 by 5.393%.

  • Which is a Better Dividend Stock ISRG or SYK?

    Intuitive Surgical has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Stryker offers a yield of 0.88% to investors and pays a quarterly dividend of $0.84 per share. Intuitive Surgical pays -- of its earnings as a dividend. Stryker pays out 40.73% of its earnings as a dividend. Stryker's payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.

  • Which has Better Financial Ratios ISRG or SYK?

    Intuitive Surgical quarterly revenues are $2.4B, which are smaller than Stryker quarterly revenues of $6.4B. Intuitive Surgical's net income of $685.7M is higher than Stryker's net income of $546M. Notably, Intuitive Surgical's price-to-earnings ratio is 75.58x while Stryker's PE ratio is 47.62x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Intuitive Surgical is 21.00x versus 6.31x for Stryker. Usually stocks with elevated PS ratios are considered overvalued.

    Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income
    ISRG
    Intuitive Surgical
    21.00x 75.58x $2.4B $685.7M
    SYK
    Stryker
    6.31x 47.62x $6.4B $546M
  • Which has Higher Returns ISRG or TFX?

    Teleflex has a net margin of 28.41% compared to Intuitive Surgical's net margin of -17.18%. Intuitive Surgical's return on equity of 15.6% beat Teleflex's return on equity of 1.57%.

    Company Gross Margin Earnings Per Share Invested Capital
    ISRG
    Intuitive Surgical
    68.04% $1.88 $16.5B
    TFX
    Teleflex
    55.31% -$2.95 $5.9B
  • What do Analysts Say About ISRG or TFX?

    Intuitive Surgical has a consensus price target of $632.53, signalling upside risk potential of 30.57%. On the other hand Teleflex has an analysts' consensus of $168.21 which suggests that it could grow by 22.15%. Given that Intuitive Surgical has higher upside potential than Teleflex, analysts believe Intuitive Surgical is more attractive than Teleflex.

    Company Buy Ratings Hold Ratings Sell Ratings
    ISRG
    Intuitive Surgical
    14 10 0
    TFX
    Teleflex
    1 11 0
  • Is ISRG or TFX More Risky?

    Intuitive Surgical has a beta of 1.426, which suggesting that the stock is 42.616% more volatile than S&P 500. In comparison Teleflex has a beta of 1.211, suggesting its more volatile than the S&P 500 by 21.134%.

  • Which is a Better Dividend Stock ISRG or TFX?

    Intuitive Surgical has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Teleflex offers a yield of 0.99% to investors and pays a quarterly dividend of $0.34 per share. Intuitive Surgical pays -- of its earnings as a dividend. Teleflex pays out 91.2% of its earnings as a dividend. Teleflex's payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.

  • Which has Better Financial Ratios ISRG or TFX?

    Intuitive Surgical quarterly revenues are $2.4B, which are larger than Teleflex quarterly revenues of $795.4M. Intuitive Surgical's net income of $685.7M is higher than Teleflex's net income of -$136.7M. Notably, Intuitive Surgical's price-to-earnings ratio is 75.58x while Teleflex's PE ratio is 96.98x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Intuitive Surgical is 21.00x versus 2.13x for Teleflex. Usually stocks with elevated PS ratios are considered overvalued.

    Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income
    ISRG
    Intuitive Surgical
    21.00x 75.58x $2.4B $685.7M
    TFX
    Teleflex
    2.13x 96.98x $795.4M -$136.7M

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Is the Market Going to Go Lower?
Is the Market Going to Go Lower?

The last month has been extremely difficult for the stock…

2 Dividend Stocks to Buy in a Recession
2 Dividend Stocks to Buy in a Recession

While many economists and investors initially expected 2025 to be…

Is Ford Stock Undervalued Amid the EV Transition?
Is Ford Stock Undervalued Amid the EV Transition?

There is a lot going on in the electric vehicle…

Stock Ideas

Buy
52
Is AAPL Stock a Buy?

Market Cap: $3.2T
P/E Ratio: 35x

Buy
56
Is NVDA Stock a Buy?

Market Cap: $3T
P/E Ratio: 41x

Buy
53
Is MSFT Stock a Buy?

Market Cap: $2.9T
P/E Ratio: 33x

Alerts

Sell
49
SMTC alert for Mar 17

Semtech [SMTC] is down 0.49% over the past day.

Buy
62
PLPC alert for Mar 17

Preformed Line Products [PLPC] is up 3.8% over the past day.

Sell
50
NUTX alert for Mar 17

Nutex Health [NUTX] is up 4.82% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock